University of Barcelona / IBMB-CSIC
designed "celiacase," a recombinant enzyme active at gastric pH that degrades gluten immunogenic peptides — including the 33-mer fragment from wheat alpha-gliadin — synergistically with pepsin before they reach the duodenum, reducing intestinal atrophy, inflammation, antibody response and dysbiosis in mouse models;…
- Country
- Spain
Coverage
| CN | EU | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
Regulatorsemafda
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Enzymatic therapy for celiac | food-alt-protein | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.